Merck | MRK - Gross Profit On Sales


Merck reported EUR3.07B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Adidas EUR 3.37B 281M Mar/2026
Adyen EUR 1.08B 788.66M Dec/2024
Akzo Nobel EUR 936M 102M Dec/2025
Alcon AG USD 1.69B 175M Mar/2026
Amadeus IT EUR 754.9M 225.7M Mar/2026
Amarin USD 23.17M 961K Dec/2025
AstraZeneca USD 12.61B 225M Mar/2026
BASF EUR 3.11B 55M Dec/2025
Bayer EUR 6.94B 1.58B Dec/2025
Beiersdorf EUR 1.54B 1.16B Jun/2025
Covestro EUR 212M 276M Dec/2025
Danone EUR 6.82B 23M Dec/2024
Fresenius EUR 1.51B 214M Dec/2025
Fresenius Medical Care EUR 1.18B 210M Mar/2026
Genmab DKK 977M 13M Dec/2025
Givaudan CHF 1.55B 140M Dec/2025
GlaxoSmithKline GBP 5.75B 429M Mar/2026
GRIFOLS EUR 686.84M 56.95M Dec/2025
Hikma Pharmaceutical USD 362.5M 329.5M Jun/2025
Infineon EUR 1.48B 15M Mar/2026
Lakefront Biotherapeutics EUR 1.68M 898.68M Mar/2026
Linde USD 3.27B 969M Dec/2025
Lonza CHF 1.29B 248M Jun/2025
Merck EUR 3.07B 104M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Philips EUR 1.77B 522M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
UCB EUR 3.19B 621M Dec/2025